Nrc Health (NRC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $20.15, -4.55% vs the prior close of $21.11.
- Volume 70.87K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NRC slides 4.5% to $20.15. Closed at $20.15, -4.55% vs the prior close of $21.11. Day range $19.98–$21.23, opened at $21.14.
NRC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NRC slides 4.5% to $20.15
- Closed at $20.15, -4.55% vs the prior close of $21.11. Day range $19.98–$21.23, opened at $21.14.
- Volume was 70.87K shares, 0.6x its 50-day average of 118.91K — lighter than usual.
- Price is -4.4% vs its 50-day average ($21.09) and +5.8% vs its 200-day average ($19.05).
- 52-week range $11.20–$23.68; today's close sits at 72% of that range, 14.9% below the 52-week high.
Oct 15, 2026 — NRC jumps 3.3% to $21.11
- Closed at $21.11, +3.33% vs the prior close of $20.43. Day range $20.61–$21.50, opened at $20.61.
- Volume was 98.50K shares, 0.8x its 50-day average of 118.98K.
- Price is +0.2% vs its 50-day average ($21.07) and +10.9% vs its 200-day average ($19.04).
- 52-week range $11.20–$23.68; today's close sits at 79% of that range, 10.9% below the 52-week high.
Oct 14, 2026 — NRC rises 1.3% to $20.43
- Closed at $20.43, +1.29% vs the prior close of $20.17. Day range $19.97–$20.49, opened at $20.03.
- Volume was 78.80K shares, 0.7x its 50-day average of 120.28K.
- Price is -2.9% vs its 50-day average ($21.04) and +7.3% vs its 200-day average ($19.03).
- 52-week range $11.01–$23.68; today's close sits at 74% of that range, 13.7% below the 52-week high.
Oct 13, 2026 — NRC dips 1.2% to $20.17
- Closed at $20.17, -1.18% vs the prior close of $20.41. Day range $20.08–$20.75, opened at $20.57.
- Volume was 58.90K shares, 0.5x its 50-day average of 121.22K — lighter than usual.
- Price is -4.1% vs its 50-day average ($21.03) and +6.0% vs its 200-day average ($19.02).
- 52-week range $11.01–$23.68; today's close sits at 72% of that range, 14.8% below the 52-week high.
Oct 12, 2026 — NRC rises 0.4% to $20.41
- Closed at $20.41, +0.39% vs the prior close of $20.33. Day range $20.11–$20.58, opened at $20.43.
- Volume was 48.70K shares, 0.4x its 50-day average of 123.60K — lighter than usual.
- Price is -2.9% vs its 50-day average ($21.01) and +7.3% vs its 200-day average ($19.02).
- 52-week range $11.01–$23.68; today's close sits at 74% of that range, 13.8% below the 52-week high.
Oct 9, 2026 — NRC dips 0.4% to $20.33
- Closed at $20.33, -0.44% vs the prior close of $20.42. Day range $20.01–$20.64, opened at $20.46.
- Volume was 52.60K shares, 0.4x its 50-day average of 125.37K — lighter than usual.
- Price is -3.2% vs its 50-day average ($20.99) and +6.9% vs its 200-day average ($19.01).
- 52-week range $11.01–$23.68; today's close sits at 74% of that range, 14.1% below the 52-week high.
Oct 8, 2026 — NRC rises 1.1% to $20.42
- Closed at $20.42, +1.14% vs the prior close of $20.19. Day range $20.11–$20.52, opened at $20.18.
- Volume was 99.20K shares, 0.8x its 50-day average of 128.05K.
- Price is -2.6% vs its 50-day average ($20.97) and +7.5% vs its 200-day average ($19.00).
- 52-week range $11.01–$23.68; today's close sits at 74% of that range, 13.8% below the 52-week high.
Oct 7, 2026 — NRC rises 0.5% to $20.19
- Closed at $20.19, +0.55% vs the prior close of $20.08. Day range $19.85–$20.46, opened at $19.97.
- Volume was 68.60K shares, 0.5x its 50-day average of 128.92K — lighter than usual.
- Price is -3.5% vs its 50-day average ($20.92) and +6.3% vs its 200-day average ($18.99).
- 52-week range $11.01–$23.68; today's close sits at 72% of that range, 14.7% below the 52-week high.
Oct 6, 2026 — NRC slides 3.4% to $20.08
- Closed at $20.08, -3.37% vs the prior close of $20.78. Day range $20.06–$20.86, opened at $20.86.
- Volume was 80.00K shares, 0.6x its 50-day average of 128.48K.
- Price is -4.2% vs its 50-day average ($20.97) and +5.7% vs its 200-day average ($18.99).
- 52-week range $11.01–$23.68; today's close sits at 72% of that range, 15.2% below the 52-week high.
Oct 5, 2026 — NRC rises 2.1% to $20.78
- Closed at $20.78, +2.11% vs the prior close of $20.35. Day range $20.22–$21.15, opened at $20.44.
- Volume was 117.70K shares, 0.9x its 50-day average of 127.04K.
- Price is -1.0% vs its 50-day average ($20.99) and +9.5% vs its 200-day average ($18.98).
- 52-week range $11.01–$23.68; today's close sits at 77% of that range, 12.2% below the 52-week high.
Oct 2, 2026 — NRC slides 4.5% to $20.35
- Closed at $20.35, -4.55% vs the prior close of $21.32. Day range $20.28–$21.53, opened at $21.41.
- Volume was 124.20K shares, 1.0x its 50-day average of 126.32K.
- Price is -3.1% vs its 50-day average ($21.00) and +7.3% vs its 200-day average ($18.97).
- 52-week range $11.01–$23.68; today's close sits at 74% of that range, 14.1% below the 52-week high.
NRC latest news & SEC filings
Every SEC filing by or about NRC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $35.39M (prior year $34.04M) (+4.0% vs Jun 30, 2025)
- Net income: -$3.28M (prior year -$106.00K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.15 (prior year -$0.01) (loss widened vs Jun 30, 2025)
Jul 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade NRC
- Last results release: Jul 28, 2026 (8-K Item 2.02). Previous ones: Apr 28, 2026, Feb 3, 2026, Oct 27, 2025. Based on that rhythm, the next report is likely around Oct 27, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.43% (largest 5.7%).
- Liquidity: about 104.17K shares (≈$2.10M) trade per day on average.
- 52-week position: $20.15 vs a range of $11.20–$23.68 (72% of the range).
- Dividends: last ex-dividend date Sep 25, 2026 ($0.16/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Shane R Harrison bought 8,000 shares on Feb 17, 2026.
- Latest filings: 8-K Aug 11, 2026; 10-Q Aug 4, 2026; 8-K Jul 28, 2026.
- Share count: 22.12M shares outstanding (Jul 31, 2026), -4.1% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
NRC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 21.14 | 21.23 | 19.98 | 20.15 | 70.87K |
| Oct 15, 2026 | 20.61 | 21.50 | 20.61 | 21.11 | 98.50K |
| Oct 14, 2026 | 20.03 | 20.49 | 19.97 | 20.43 | 78.80K |
| Oct 13, 2026 | 20.57 | 20.75 | 20.08 | 20.17 | 58.90K |
| Oct 12, 2026 | 20.43 | 20.58 | 20.11 | 20.41 | 48.70K |
| Oct 9, 2026 | 20.46 | 20.64 | 20.01 | 20.33 | 52.60K |
| Oct 8, 2026 | 20.18 | 20.52 | 20.11 | 20.42 | 99.20K |
| Oct 7, 2026 | 19.97 | 20.46 | 19.85 | 20.19 | 68.60K |
| Oct 6, 2026 | 20.86 | 20.86 | 20.06 | 20.08 | 80.00K |
| Oct 5, 2026 | 20.44 | 21.15 | 20.22 | 20.78 | 117.70K |
| Oct 2, 2026 | 21.41 | 21.53 | 20.28 | 20.35 | 124.20K |
| Oct 1, 2026 | 21.15 | 21.82 | 20.98 | 21.32 | 176.20K |
| Sep 30, 2026 | 21.10 | 21.56 | 20.68 | 21.19 | 142.70K |
| Sep 29, 2026 | 19.92 | 21.08 | 19.77 | 21.05 | 135.90K |
| Sep 28, 2026 | 19.36 | 20.15 | 19.18 | 20.06 | 83.30K |
| Sep 25, 2026 | 20.23 | 20.28 | 19.55 | 19.57 | 139.20K |
| Sep 24, 2026 | 21.41 | 21.77 | 20.09 | 20.35 | 112.60K |
| Sep 23, 2026 | 21.81 | 21.96 | 21.36 | 21.57 | 106.00K |
| Sep 22, 2026 | 21.32 | 21.93 | 21.32 | 21.86 | 131.00K |
| Sep 21, 2026 | 20.58 | 21.89 | 20.43 | 21.27 | 158.50K |
About Nrc Health
Nrc Health (NRC) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in LINCOLN, NE. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 70487.
NRC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Donald M Berwick | Director | Jun 25, 2026 |
| Parul Bhandari | Director | Jun 25, 2026 |
| Michael D. Hays | Chairman | Jan 7, 2026 |
| Stephen H Lockhart | Director | Jun 25, 2026 |
| John N Nunnelly | Director | Jun 25, 2026 |
| Penny Ann Wheeler | Director | Jun 25, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Burik | EVP, Strategic Insights | Jan 16, 2026 |
| Shane R Harrison | EVP & Chief Financial Officer | Feb 19, 2026 |
| Michael D. Hays | Chairman | Jan 7, 2026 |
| Helen Hrdy | EVP & Chief Operating Officer | Dec 17, 2025 |
| Jason Russell Rau | Executive Vice President | Mar 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Feb 17, 2026 | Shane R Harrison | Buy | 8,000 | $12.27 |
| Feb 17, 2026 | Shane R Harrison | Buy | 8,000 | $12.27 |
| Feb 17, 2026 | Shane R Harrison | Buy | 8,000 | $12.27 |
| Feb 17, 2026 | Shane R Harrison | Buy | 8,000 | $12.27 |
NRC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $137.39M | — | 50.00 | $26.45M |
| Dec 31, 2024 | $143.06M | — | 1.04 | $34.62M |
| Dec 31, 2023 | $148.58M | — | 1.25 | $38.11M |
| Dec 31, 2022 | $151.57M | — | 1.27 | $36.27M |
| Dec 31, 2021 | $147.95M | — | 1.46 | $46.34M |
Latest balance sheet: total assets $136.15M, total liabilities $129.60M, cash $3.33M (as of Jun 30, 2026).
NRC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 28, 2026 | 8-K Item 2.02 (results) | $22.34 |
| Apr 28, 2026 | 8-K Item 2.02 (results) | $16.84 |
| Feb 3, 2026 | 8-K Item 2.02 (results) | $17.62 |
| Oct 27, 2025 | 8-K Item 2.02 (results) | $11.42 |
| Jul 28, 2025 | 8-K Item 2.02 (results) | $13.94 |
| Apr 28, 2025 | 8-K Item 2.02 (results) | $10.84 |
| Jan 27, 2025 | 8-K Item 2.02 (results) | $18.73 |
| Oct 25, 2024 | 8-K Item 2.02 (results) | $17.96 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 13, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Icon (ICLR)Medpace (MEDP)Absci (ABSI)bioAffinity Technologies (BIAF)OmniAb (OABI)Maxcyte (MXCT)iSpecimen (ISPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NRC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.